Summary
Donald Raymond is an Associate Director of Protein Engineering with 11 years of structural biology experience focused on therapeutic and antibody discovery for infectious disease and oncology. He combines hands-on expertise in molecular cloning, multi-system protein expression, crystallography, and biophysical characterization with proven leadership in building and mentoring cross-functional teams at institutions like Broad Institute and Apriori Bio. Donald has led partnered therapeutics projects with Big Pharma and driven variant-resistant vaccine efforts, translating challenging structural problems—including low-resolution and difficult crystal systems—into actionable drug and antigen designs. His PhD work revealed a novel genome-packaging strategy for Bunyaviridae, underscoring a career-long ability to uncover non-obvious biological mechanisms and apply them to translational science. Based in Boston, he is skilled at bridging protein engineering, automation, and immunology to accelerate therapeutic pipelines.
11 years of coding experience
13 years of employment as a software developer
B.Sc Biology Philosophy, B.Sc Biology Philosophy at Temple University
Ph.D. Biological Chemistry, Ph.D. Biological Chemistry at University of Michigan